A preliminary study has found that efavirenz — a non-nucleoside inhibitor of HIV virus that is used for treating HIV/AIDS — can be repurposed for the treatment of chikungunya. Currently ...

(1 Trusted Source HIV weakens the immune system by attacking infection-fighting cells. While antiretroviral therapy controls the virus, it doesn’t cure it. Mount Sinai researchers ...

Weight trajectories differed significantly among patients with HIV during the first year of ART, with no associations observed between weight gain and type of ART regimen.

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...

Disparities in HIV diagnosis rates were observed between Black and White individuals in the US from 2017 to 2021.

The BBC was reporting on a trial vaccine that contained an HIV protein, not the virus itself, and which was never rolled out to the public. A viral Facebook post claims that a video shows how the BBC ...

Among the signatories was French scientist Francoise Barre-Sinoussi, who won a 1983 medicine Nobel prize for her work identifying the HIV virus. The US government has said the funding cuts were ...

US President Donald Trump’s recent executive order to freeze USAID’s funding means Nyumbani’s access to life-saving antiretroviral drugs, which stop the HIV virus from replicating in the ...

When in 1985 it became possible to test for HIV, the virus that causes AIDS, the prospect of named surveillance triggered deep fears about stigma and discrimination. The prospect of reporting the ...

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.